Search - tctmd.com

Displaying 1 - 20 of 219

Sort: Relevancy | Date

News Conference News AHA 2025

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

Michael O'Riordan

November 11, 2025

News Conference News ESC 2025

ESC Guidelines Update Clarifies Pregnancy Risks and Choices in Women With CVD

L.A. McKeown

September 09, 2025

News Daily News

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

L.A. McKeown

March 06, 2025

Presentation TCT 2024

TCT 583: Influence of Heparin-Induced Thrombocytopenia on In-Hospital Outcomes in Patients With Left Ventricular Assist Devices (LVAD): A Decade-Long Study

Presenter: Neethi Dasu

October 30, 2024

News Conference News TCT 2024

In STEMI, Giving Heparin Pre-Cath Lab May Boost Reperfusion: HELP-PCI

Yael L. Maxwell

October 29, 2024

Presentation TCT 2024

TCT 235: Efficacy and Safety of Bivalirudin and Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients Who Underwent Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis

Presenter: Hamza Naveed

October 28, 2024

Presentation TCT 2024

Early Administration of Heparin at First Medical Contact Versus in the Cathlab for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention (HELP-PCI): A Multicenter, Randomized Trial

Presenter: Jing Chen

October 28, 2024

Presentation TCT 2024

Early Administration of Heparin at First Medical Contact Versus in the Cathlab for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention (HELP-PCI): A Multicenter, Randomized Trial

Presenter: Jing Chen

October 28, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Daily News

Point-of-Care High-Sensitivity Assay for Troponin I Compares Well With Central Labs

L.A. McKeown

August 15, 2024

Presentation TCT 2023

TCT 215: Safety of Bivalirudin Versus Heparin in Patients With ST-elevation Myocardial Infarction: a Systematic Review and Meta-analysis:

Presenter: Mostafa Elbanna

October 26, 2023

Presentation TCT 2023

TCT 538: Comparison of Limb Outcome between Hemodialysis and Non-hemodialysis Patients following Heparin-bonded Stent Graft Implantation for Femoropopliteal Lesion from LANDMARK registry

Presenter: Kazuki Tobita

October 25, 2023

Presentation TCT 2023

TCT 42: Does Heparin-induced thrombocytopenia affect in-hospital outcomes in patients presenting with ST-segment elevation myocardial infarction? A nationwide data analysis.

Presenter: Purveshkumar Patel

October 25, 2023

$Unfractionated Heparin Still Works for Primary PCI!$

Presentation TCT 2023

Unfractionated Heparin Still Works for Primary PCI!

Presenter: Rod Stables

October 25, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Conference News ESC 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Michael O'Riordan

September 06, 2023

News Daily News

Prehospital Cath Lab Activation in Australia Linked to Better STEMI Survival

L.A. McKeown

July 20, 2023

News Daily News

A Bivalirudin Rebuttal: ‘Some Issues’ to Discuss With BRIGHT-4

Shelley Wood

April 14, 2023

News Daily News

Top Coronary Artery Disease News of 2022

Yael L. Maxwell

December 29, 2022

News Opinion CV Team Dispatch

December 2022 News Roundup

L.A. McKeown

December 28, 2022

Advertisement

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

ESC Guidelines Update Clarifies Pregnancy Risks and Choices in Women With CVD

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

TCT 583: Influence of Heparin-Induced Thrombocytopenia on In-Hospital Outcomes in Patients With Left Ventricular Assist Devices (LVAD): A Decade-Long Study

In STEMI, Giving Heparin Pre-Cath Lab May Boost Reperfusion: HELP-PCI

TCT 235: Efficacy and Safety of Bivalirudin and Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients Who Underwent Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis

Early Administration of Heparin at First Medical Contact Versus in the Cathlab for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention (HELP-PCI): A Multicenter, Randomized Trial

Early Administration of Heparin at First Medical Contact Versus in the Cathlab for STEMI Patients Undergoing Primary Percutaneous Coronary Intervention (HELP-PCI): A Multicenter, Randomized Trial

What’s Going to Be Big at TCT 2024?

Point-of-Care High-Sensitivity Assay for Troponin I Compares Well With Central Labs

TCT 215: Safety of Bivalirudin Versus Heparin in Patients With ST-elevation Myocardial Infarction: a Systematic Review and Meta-analysis:

TCT 538: Comparison of Limb Outcome between Hemodialysis and Non-hemodialysis Patients following Heparin-bonded Stent Graft Implantation for Femoropopliteal Lesion from LANDMARK registry

TCT 42: Does Heparin-induced thrombocytopenia affect in-hospital outcomes in patients presenting with ST-segment elevation myocardial infarction? A nationwide data analysis.

Unfractionated Heparin Still Works for Primary PCI!

October 2023 News Roundup

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Prehospital Cath Lab Activation in Australia Linked to Better STEMI Survival

A Bivalirudin Rebuttal: ‘Some Issues’ to Discuss With BRIGHT-4

Top Coronary Artery Disease News of 2022

December 2022 News Roundup

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content